Enzymatic Therapy and Twinlab to market the dietary supplement following the expiration of GNC's initially exclusive distribution rights; the retailer will continue to market the product ("The Tan Sheet" Feb. 2, p. 13). Green Bay, Wisc.-based Enzymatic Therapy plans to introduce a 60-count 7-Keto in 25 mg capsules at health food stores beginning June 30; ET will discontinue its other DHEA products. Humanetics is advertising the brand in consumer health magazines including Natural Health, Let's Live, Delicious and Vegetarian Times; ET has no plans for additional advertising, although it will promote the product at the NNFA Marketplace in July. Hauppauge, N.Y.-based Twinlab will introduce 7-Keto in late August...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
While the first six months of the year saw eight new drugs targeting a range of diseases enter the European Medicines Agency’s priority medicines scheme, and three PRIME-designated treatments go on to win EU marketing approval, use of the accelerated assessment mechanism appears to be limited.
Stay up to date on regulatory guidelines from around the world with the Pink Sheet’s Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.